CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Takeda Pharmaceutical Company LTD. v. Teva Pharmaceuticals USA Inc.

1:09-cv-00841

Overview

Case Number 1:09-cv-00841
Filing Date 2009-11-06
Status Terminated
Termination Date 2011-08-10
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Watson Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Laura D. Hatcher

U.S. Attorney's Office

Tel: +1 (302) 573-6277

Hercules Building, 1313 N. Market Street

Watson Pharma Inc. Operating Company

Represented By

2 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Laura D. Hatcher

U.S. Attorney's Office

Tel: +1 (302) 573-6277

Hercules Building, 1313 N. Market Street

Watson Laboratories Inc. - Florida Operating Company

Represented By

5 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Samuel T. Lockner

Email: SLockner@carlsoncaspers.com

Matthew J. Goggin

Email: mgoggin@carlsoncaspers.com

Mark D. Schuman

UNDELIVERABLE EMAIL 8/30/2019

Laura D. Hatcher

U.S. Attorney's Office

Tel: +1 (302) 573-6277

Hercules Building, 1313 N. Market Street

Teva Pharmaceutical Industries Ltd. Operating Company

Represented By

8 Attorneys Listed

Tracey B. Davies

Email: tdavies@gibsondunn.com

Steven M. Lubezny

Email: steve.lubezny@dentons.com

Stephanie Lollo

Email: slollo@velaw.com

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Madeline F. Baer

Email: mbaer@velaw.com

Edward H. Rice

Email: erice@freeborn.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

9 Attorneys Listed

Tracey B. Davies

Email: tdavies@gibsondunn.com

Steven M. Lubezny

Email: steve.lubezny@dentons.com

Stephanie Lollo

Email: slollo@velaw.com

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Madeline F. Baer

Email: mbaer@velaw.com

Julie P. Samuels

Email: jsamuels@loeb.com

Edward H. Rice

Email: erice@freeborn.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Plaintiff

Takeda Pharmaceuticals North America Inc. Operating Company

Represented By

2 Attorneys Listed

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Takeda Pharmaceutical Company Ltd. Operating Company

Represented By

4 Attorneys Listed

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Preston K. Ratliff II

Email: prestonratliff@paulhastings.com

Bruce M. Wexler

Email: brucewexler@paulhastings.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 7 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (7): 🇯🇵 Japan 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6034239
Tricyclic compounds, their production and use
Filed: 1997-03-06
Issued: 2000-03-07
Expired (Term Ended) +868d PTA
Expires: 2019-07-22

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+868 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

31

Dispositive

0

Granted

0

Denied

0

Pending / Review

21

Motions by Category

Claim Construction / Markman Filing 9 Procedural / Extension Motion 8 Motion to Compel Discovery 14

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED re 141 STIPULATION TO EXTEND TIME of Various Deadlines to 07/08/2011 and 9/16/2011 filed by Watson Pharma Inc., Watson Laboratories Inc. - Florida, W...
Entry #— • 2011-06-23
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME of Various Deadlines to 07/08/2011 and 9/16/2011 - filed by Watson Laboratories Inc. - Florida, Watson Pharma Inc., Watson Pharmaceut...
Entry #141 • 2011-06-22 Document →
Claim Construction / Markman Filing Pending
Reset Scheduling Order Deadlines: Claim Construction Opening Brief due by 9/2/2011. Final Pretrial Conference set for 11/1/2011 03:30 PM in Courtroom 4B before ...
Entry #— • 2011-05-04
Claim Construction / Markman Filing Pending / Under Review
CLAIM Construction Chart by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals North America Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuti...
Entry #118 • 2011-03-01 Document →
Claim Construction / Markman Filing Pending
SO ORDERED, re 113 STIPULATION AMENDING SCHEDULING ORDER: ( Discovery due by 8/24/2011., Oral Argument set for 11/1/2011 03:30 PM in Courtroom 4B before Judge S...
Entry #— • 2011-02-23
Claim Construction / Markman Filing Pending
SO ORDERED- re 108 STIPULATION TO EXTEND TIME. ORDER- Setting Scheduling Order Deadlines ( Claim Construction Statement due by 3/1/2011.). Signed by Judge Sue L...
Entry #— • 2011-02-01

Docket Entries

(187 total)
Pleading / Complaint

COMPLAINT filed against Teva Pharmaceuticals USA Inc., Teva Pharmaceutical Industries Ltd. - Magistrate Consent Notice to Pltf. (Filing fee $ 350, receipt number 03110000000000653652.) - filed by Takeda Pharmaceutical Company LTD., Takeda Pharmaceuticals North America Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mxw, ) (Entered: 11/06/2009)

Entry #1 • 2009-11-06
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (mxw, ) (Entered: 11/06/2009)

Entry #2 • 2009-11-06
1

Disclosure Statement pursuant to Rule 7.1 filed by Takeda Pharmaceutical Company LTD., Takeda Pharmaceuticals North America Inc., identifying Corporate Parent Takeda America Holdings, Inc. for Takeda Pharmaceuticals North America Inc. (mxw, ) (Entered: 11/06/2009)

Entry #3 • 2009-11-06
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,034,239; (mxw, ) (Entered: 11/06/2009)

Entry #4 • 2009-11-06
1

Summons Issued as to Teva Pharmaceuticals USA Inc. on 11/6/2009; Teva Pharmaceutical Industries Ltd. on 11/6/2009. (mxw, )

Entry #5 • 2009-11-06
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc